- Home
- LIQT vs COCP Comparison
LIQT vs COCP Comparison
Compare LIQT & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIQT
- COCP
- Stock Information
- Founded
- LIQT 2004
- COCP 2006
- Country
- LIQT Denmark
- COCP United States
- Employees
- LIQT N/A
- COCP N/A
- Industry
- LIQT Industrial Machinery/Components
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- LIQT Technology
- COCP Health Care
- Exchange
- LIQT Nasdaq
- COCP Nasdaq
- Market Cap
- LIQT 16.1M
- COCP 15.4M
- IPO Year
- LIQT N/A
- COCP N/A
- Fundamental
- Price
- LIQT N/A
- COCP $1.25
- Analyst Decision
- LIQT Strong Buy
- COCP Strong Buy
- Analyst Count
- LIQT 2
- COCP 1
- Target Price
- LIQT $4.80
- COCP $6.00
- AVG Volume (30 Days)
- LIQT 13.9K
- COCP 4.6M
- Earning Date
- LIQT 11-13-2025
- COCP 11-12-2025
- Dividend Yield
- LIQT N/A
- COCP N/A
- EPS Growth
- LIQT N/A
- COCP N/A
- EPS
- LIQT N/A
- COCP N/A
- Revenue
- LIQT $15,459,242.00
- COCP N/A
- Revenue This Year
- LIQT $36.89
- COCP N/A
- Revenue Next Year
- LIQT $16.33
- COCP N/A
- P/E Ratio
- LIQT N/A
- COCP N/A
- Revenue Growth
- LIQT N/A
- COCP N/A
- 52 Week Low
- LIQT $1.34
- COCP $1.12
- 52 Week High
- LIQT $3.11
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- LIQT N/A
- COCP 39.39
- Support Level
- LIQT N/A
- COCP $1.19
- Resistance Level
- LIQT N/A
- COCP $1.27
- Average True Range (ATR)
- LIQT 0.00
- COCP 0.08
- MACD
- LIQT 0.00
- COCP 0.01
- Stochastic Oscillator
- LIQT 0.00
- COCP 28.57
About LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).